Schistosomiasis of the female genital tract: public health aspects.
In this paper Gabriele Poggensee, Hermann Feldmeier and Ingela Krantz discuss the public health relevance of female genital schistosomiasis (FGS). Some of the stated hypotheses are supported only by clinical observations and/or circumstantial evidence as valid epidemiological and immunological data of this disease entity are still very scanty. Morbidity caused by the presence of schistosome eggs in the lower and upper genital tract have been almost completely neglected during the past two decades. This has been acknowledged by the WHO and, in 1997, the Gender Task Force of the WHO's Tropical Disease Research Programme (TDR) included FGS in a list of scientific areas that deserve high research priority.
Poggensee
G
G
Institut für Tropenmedizin, Spandauer Damm 130, 14050 Berlin, Germany. gabriele.poggensee@charite.de
Feldmeier
H
H
Krantz
I
I
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000349:Africa / Q000453:epidemiology; D000818:Animals; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications / Q000453:epidemiology / Q000469:parasitology* / Q000652:urine; D005836:Genitalia, Female / Q000469:parasitology*; D006801:Humans; D007247:Infertility, Female / Q000150:complications; D008297:Male; D015995:Prevalence; D011634:Public Health; D012548:Schistosoma haematobium / Q000472:pathogenicity*; D012553:Schistosomiasis haematobia / Q000150:complications / Q000453:epidemiology* / Q000652:urine; D002583:Uterine Cervical Neoplasms / Q000150:complications